FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative

The Food and Drug Administration on Tuesday declined to approve a nasal spray that would have been the first needle-free alternative to injectors like EpiPen for treating severe allergic reactions, a decision that “surprised” developer ARS Pharmaceuticals and could push back the anticipated treatment’s arrival until late next year.